Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Nonrandomized Study of Autologous Muscle Derived Cell (AMDC) Transplantation for Treatment of Fecal Incontinence

NCT01600755 is registered in ClinicalTrials.gov with Cook MyoSite as lead sponsor.

NCT NCT01600755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01600755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Nonrandomized Study of Autologous Muscle Derived Cell (AMDC) Transplantation for Treatment of Fecal Incontinence
Lead sponsor
Cook MyoSite
Phase
Phase 1/2
Overall status
Completed
Start date
March 28, 2013
Completion date
October 27, 2021
Enrollment
53 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fecal incontinence